Amanote Research
Register
Sign In
Melanocytic Signaling Promotes Resistance to MAPK Inhibition
Cancer Discovery
- United States
doi 10.1158/2159-8290.cd-rw2013-252
Full Text
Open PDF
Abstract
Available in
full text
Categories
Oncology
Date
November 14, 2013
Authors
Unknown
Publisher
American Association for Cancer Research (AACR)
Related search
809 Pou4f1 Promotes Braf Inhibitor Resistance by Reactivating Mapk Signaling Pathway in Melanoma
Journal of Investigative Dermatology
Biochemistry
Dermatology
Cell Biology
Molecular Biology
PAK Signaling Promotes Acquired Resistance to BRAF and MEK Inhibitors
Cancer Discovery
Oncology
Activation of MAPK Signaling by CXCR7 Leads to Enzalutamide Resistance in Prostate Cancer
Cancer Research
Cancer Research
Oncology
Inhibition of MAPK/ERK Pathway Promotes Oligodendrocytes Generation and Recovery of Demyelinating Diseases
GLIA
Molecular Neuroscience
Neurology
Cellular
P38α-Mapk Signaling Inhibition Attenuates Soleus Atrophy During Early Stages of Muscle Unloading
International Journal of Molecular Sciences
Organic Chemistry
Molecular Biology
Theoretical Chemistry
Inorganic Chemistry
Computer Science Applications
Spectroscopy
Medicine
Catalysis
Physical
Linc-RoR Promotes MAPK/ERK Signaling and Confers Estrogen-Independent Growth of Breast Cancer
Molecular Cancer
Cancer Research
Oncology
Molecular Medicine
MYH9 Promotes Growth and Metastasis via Activation of MAPK/AKT Signaling in Colorectal Cancer
Journal of Cancer
Oncology
PEA15 Promotes Liver Metastasis of Colorectal Cancer by Upregulating the ERK/MAPK Signaling Pathway
Oncology Reports
Medicine
Cancer Research
Oncology
Broad-Spectrum Inhibition of Respiratory Virus Infection by MicroRNA Mimics Targeting P38 MAPK Signaling
Molecular Therapy - Nucleic Acids
Drug Discovery
Molecular Medicine